Stay updated on Secukinumab in AS: Clinical Trial

Sign up to get notified when there's something new on the Secukinumab in AS: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Secukinumab in AS: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T03:02:10.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The completed secukinumab trial record is now displayed, including its study design, measured outcomes, locations, publications, and participant-data sharing information, in place of a 403 error page.
    Difference
    93%
    Check dated 2026-11-11T02:03:07.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer now shows revision v3.8.0 instead of v3.7.2, while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-04T00:32:11.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A site-wide NIH transition notice appears above the ClinicalTrials.gov 403 error page, and the displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:30:57.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The 403 error page’s footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:35:31.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous study content with an access notice. This indicates an access restriction rather than an update to the study details or related information.
    Difference
    18%
    Check dated 2026-09-23T00:39:35.000Z thumbnail image

Stay in the know with updates to Secukinumab in AS: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Secukinumab in AS: Clinical Trial page.